{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:22:21Z","timestamp":1779938541010,"version":"3.53.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2701700, 2021YFC2701704"],"award-info":[{"award-number":["2021YFC2701700, 2021YFC2701704"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11634-7","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:10:04Z","timestamp":1759173004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical score for early escalation in pediatric A2063G Mycoplasma pneumoniae pneumonia: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Junjie","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"issue":"6","key":"11634_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/j.1574-6976.2008.00129.x","volume":"32","author":"TP Atkinson","year":"2008","unstructured":"Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32(6):956\u201373.","journal-title":"FEMS Microbiol Rev"},{"issue":"6","key":"11634_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3345\/kjp.2017.60.6.167","volume":"60","author":"HJ Yang","year":"2017","unstructured":"Yang HJ, Song DJ, Shim JY. Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr. 2017;60(6):167\u201374.","journal-title":"Korean J Pediatr"},{"key":"11634_CR3","doi-asserted-by":"crossref","unstructured":"Oishi T, Yoshioka D, Nakano T, Ouchi K. Recent Trend of Antimicrobial Susceptibility among Mycoplasma pneumoniae Isolated from Japanese Children. Microorganisms. 2022;10(12):2428. Published 2022 Dec 8.","DOI":"10.3390\/microorganisms10122428"},{"key":"11634_CR4","doi-asserted-by":"publisher","first-page":"1115009","DOI":"10.3389\/fped.2023.1115009","volume":"11","author":"M Leng","year":"2023","unstructured":"Leng M, Yang J, Zhou J. The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children. Front Pediatr. 2023;11:1115009. Published 2023 Mar 2.","journal-title":"Front Pediatr"},{"key":"11634_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijid.2019.03.028","volume":"83","author":"J Qu","year":"2019","unstructured":"Qu J, Chen S, Bao F, Gu L, Cao B. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China. Int J Infect Dis. 2019;83:26\u201331.","journal-title":"Int J Infect Dis"},{"key":"11634_CR6","doi-asserted-by":"publisher","first-page":"1449511","DOI":"10.3389\/fmicb.2024.1449511","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Jia X, Gao Y, Ren X, Du B, Zhao H, et al. Increased macrolide resistance rate of Mycoplasma pneumoniae correlated with epidemic in Beijing, China in 2023. Front Microbiol. 2024;15:1449511 Published 2024 Aug 6.","journal-title":"Front Microbiol."},{"key":"11634_CR7","doi-asserted-by":"crossref","unstructured":"Jiang Y, Dou H, Xu B, Xu B, Zhou W, Wang H, et al. Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019. Epidemiol Infect. 2024;152 Published 2024 Apr 18.","DOI":"10.1017\/S0950268824000323"},{"issue":"11","key":"11634_CR8","doi-asserted-by":"publisher","first-page":"e00968","DOI":"10.1128\/JCM.00968-19","volume":"57","author":"KB Waites","year":"2019","unstructured":"Waites KB, Ratliff A, Crabb DM, Xiao L, Qin X, Selvarangan R, et al. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. J Clin Microbiol. 2019;57(11):e00968-19 Published 2019 Oct 23.","journal-title":"J Clin Microbiol."},{"issue":"4","key":"11634_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/antibiotics10040393","volume":"10","author":"A Romandini","year":"2021","unstructured":"Romandini A, Pani A, Schenardi PA, Pattarino GAC, De Giacomo C, Scaglione F. Antibiotic Resistance in Pediatric Infections: Global Emerging Threats, Predicting the Near Future. Antibiotics (Basel). 2021;10(4):393 Published 2021 Apr 6.","journal-title":"Antibiotics (Basel)."},{"issue":"5","key":"11634_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/jcm8050726","volume":"8","author":"EA Yang","year":"2019","unstructured":"Yang EA, Kang HM, Rhim JW, Kang JH, Lee KY. Early corticosteroid therapy for Mycoplasma pneumoniae pneumonia irrespective of used antibiotics in children. J Clin Med. 2019;8(5):726. Published 2019 May 22.","journal-title":"J Clin Med"},{"issue":"1","key":"11634_CR11","doi-asserted-by":"publisher","first-page":"14860","DOI":"10.1038\/s41598-025-99537-0","volume":"15","author":"D Kang","year":"2025","unstructured":"Kang D, Yun KW, Lee T, Cho EY, Eun BW, Lee JK, et al. Treatment modalities for fever duration in children with Mycoplasma pneumoniae pneumonia. Sci Rep. 2025;15(1):14860 Published 2025 Apr 28.","journal-title":"Sci Rep."},{"key":"11634_CR12","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.2147\/IDR.S466994","volume":"17","author":"J Cheng","year":"2024","unstructured":"Cheng J, Liu Y, Zhang G, Tan L, Luo Z. Azithromycin effectiveness in children with mutated Mycoplasma pneumoniae pneumonia. Infect Drug Resist. 2024;17:2933\u201342. Published 2024 Jul 11.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"11634_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jmii.2018.09.009","volume":"52","author":"TI Yang","year":"2019","unstructured":"Yang TI, Chang TH, Lu CY, Chen JM, Lee PI, Huang LM, et al. Mycoplasma pneumoniae in pediatric patients: do macrolide-resistance and\/or delayed treatment matter? J Microbiol Immunol Infect. 2019;52(2):329\u201335.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"11634_CR14","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1038\/s41598-024-55311-2","volume":"14","author":"P Li","year":"2024","unstructured":"Li P, Wang W, Zhang X, Pan J, Gong L. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases. Sci Rep. 2024;14(1):5632 (Published 2024 Mar 7).","journal-title":"Sci Rep"},{"issue":"11","key":"11634_CR15","first-page":"16","volume":"20","author":"National Health Commission of the People\u2019s Republic of China","year":"2023","unstructured":"National Health Commission of the People\u2019s Republic of China. Guidelines for diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023 edition). Chin J Ration Drug Use. 2023;20(11):16\u201324.","journal-title":"Chin J Ration Drug Use"},{"issue":"4","key":"11634_CR16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s15010-024-02467-8","volume":"53","author":"C Fu","year":"2025","unstructured":"Fu C, Mo L, Feng Y, Zhu N, Huang H, Huang Z, et al. Detection of Mycoplasma pneumoniae in hospitalized pediatric patients presenting with acute lower respiratory tract infections utilizing targeted next-generation sequencing. Infection. 2025;53(4):1437\u201347.","journal-title":"Infection"},{"issue":"1","key":"11634_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12887-024-05380-z","volume":"25","author":"D Lian","year":"2025","unstructured":"Lian D, Lin C, Zhang Z, Wei J, Wang D, Tang Q. Clinical diagnostic value of throat swabs in pediatric acute lower respiratory tract infections using targeted next-generation sequencing. BMC Pediatr. 2025;25(1):224. Published 2025 Mar 21.","journal-title":"BMC Pediatr"},{"issue":"9","key":"11634_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12519-024-00831-0","volume":"20","author":"YS Wang","year":"2024","unstructured":"Wang YS, Zhou YL, Bai GN, Li SX, Xu D, Chen LN, et al. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. World J Pediatr. 2024;20(9):901\u201314.","journal-title":"World J Pediatr"},{"issue":"8","key":"11634_CR19","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1007\/s00330-020-06817-6","volume":"30","author":"K Li","year":"2020","unstructured":"Li K, Fang Y, Li W, Pan C, Qin P, Zhong Y, et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020;30(8):4407\u201316.","journal-title":"Eur Radiol"},{"issue":"5","key":"11634_CR20","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s00330-021-08435-2","volume":"32","author":"A Inoue","year":"2022","unstructured":"Inoue A, Takahashi H, Ibe T, Ishii H, Kurata Y, Ishizuka Y, et al. Comparison of semiquantitative chest CT scoring systems to estimate severity in coronavirus disease 2019 (COVID-19) pneumonia. Eur Radiol. 2022;32(5):3513\u201324.","journal-title":"Eur Radiol"},{"issue":"5","key":"11634_CR21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/jpc.15839","volume":"58","author":"C \u00c7etin","year":"2022","unstructured":"\u00c7etin C, Karaaslan A, Ak\u0131n Y, Arifoglu M, Rona G, Demirhan R. Relationship of chest computed tomography score with disease severity and laboratory values in children with COVID-19. J Paediatr Child Health. 2022;58(5):802\u20138.","journal-title":"J Paediatr Child Health"},{"issue":"12","key":"11634_CR22","doi-asserted-by":"publisher","first-page":"111503","DOI":"10.1016\/j.isci.2024.111503","volume":"27","author":"Y Lu","year":"2024","unstructured":"Lu Y, Li WJ, Wang XX, Huang AQ, Cheng H. Risk factors and prescription patterns analysis for macrolide-resistant Mycoplasma pneumoniae pneumonia in children. iScience. 2024;27(12):111503. Published 2024 Nov 29.","journal-title":"iScience"},{"key":"11634_CR23","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.2147\/JIR.S321656","volume":"14","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Zhang T, Zhu B, Bi Y, Jiang SW, Zhu Y, et al. Increasing age affected polymorphonuclear neutrophils in prognosis of Mycoplasma pneumoniae pneumonia. J Inflamm Res. 2021;14:3933\u201343. Published 2021 Aug 14.","journal-title":"J Inflamm Res"},{"issue":"1","key":"11634_CR24","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1038\/s41598-025-94292-8","volume":"15","author":"L Yuan","year":"2025","unstructured":"Yuan L, Mingyue D, Zhou L. Analysis of the characteristics of mixed infections with Mycoplasma pneumoniae in children. Sci Rep. 2025;15(1):9414 (Published 2025 Mar 19).","journal-title":"Sci Rep"},{"issue":"1","key":"11634_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/s12879-020-05356-1","volume":"20","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Wang J, Chen W, Shen N, Tao Y, Zhao R, et al. Impact of viral coinfection and macrolide-resistant Mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2020;20(1):633 (Published 2020 Aug 26).","journal-title":"BMC Infect Dis"},{"key":"11634_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1751-0473-3-17","volume":"3","author":"Z Bursac","year":"2008","unstructured":"Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17. Published 2008 Dec 16.","journal-title":"Source Code Biol Med"},{"issue":"8","key":"11634_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1348-0421.2001.tb01293.x","volume":"45","author":"N Okazaki","year":"2001","unstructured":"Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45(8):617\u201320.","journal-title":"Microbiol Immunol"},{"issue":"1","key":"11634_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13052-024-01615-y","volume":"50","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhang Y, Tang QN, Shi HB. Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods. Ital J Pediatr. 2024;50(1):38 Published 2024 Mar 5.","journal-title":"Ital J Pediatr."},{"issue":"1 Pt 1","key":"11634_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jfma.2020.08.018","volume":"120","author":"KL Lee","year":"2021","unstructured":"Lee KL, Lee CM, Yang TL, Yen TY, Chang LY, Chen JM, et al. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010\u20132019. J Formos Med Assoc. 2021;120(1 Pt 1):281\u201391.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"11634_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12879-017-2500-z","volume":"17","author":"IA Yoon","year":"2017","unstructured":"Yoon IA, Hong KB, Lee HJ, Yun KW, Park JY, Choi YH, et al. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2017;17(1):402. Published 2017 Jun 7.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"11634_CR31","volume":"6","author":"H Gingras","year":"2020","unstructured":"Gingras H, Patron K, Leprohon P, Ouellette M. Azithromycin resistance mutations in Streptococcus pneumoniae as revealed by a chemogenomic screen. Microb Genom. 2020;6(11):mgen000454.","journal-title":"Microb Genom"},{"key":"11634_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jgar.2016.03.002","volume":"5","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang F, Wang H, Zhao C, Wang Z, Cao B, et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: results from the CARTIPS antimicrobial surveillance program. J Glob Antimicrob Resist. 2016;5:36\u201341.","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"11634_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jmii.2013.06.006","volume":"48","author":"CY Chiu","year":"2015","unstructured":"Chiu CY, Chen CJ, Wong KS, Tsai MH, Chiu CH, Huang YC. Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia. J Microbiol Immunol Infect. 2015;48(1):51\u20136.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"11634_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12890-022-02005-y","volume":"22","author":"S Choo","year":"2022","unstructured":"Choo S, Lee YY, Lee E. Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia. BMC Pulm Med. 2022;22(1):212. Published 2022 May 30.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"11634_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1186\/s12890-024-03380-4","volume":"24","author":"A Yu","year":"2024","unstructured":"Yu A, Ran L, Sun X, Feng T. Significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia. BMC Pulm Med. 2024;24(1):585. Published 2024 Nov 25.","journal-title":"BMC Pulm Med"},{"issue":"8 Suppl","key":"11634_CR36","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1097\/00006454-200308001-00004","volume":"22","author":"MR Jacobs","year":"2003","unstructured":"Jacobs MR, Johnson CE. Macrolide resistance: an increasing concern for treatment failure in children. Pediatr Infect Dis J. 2003;22(8 Suppl):S131-8.","journal-title":"Pediatr Infect Dis J"},{"issue":"13","key":"11634_CR37","doi-asserted-by":"publisher","first-page":"e33697","DOI":"10.1016\/j.heliyon.2024.e33697","volume":"10","author":"M Leng","year":"2024","unstructured":"Leng M, Yang J, Liu X. Macrolide-resistant Mycoplasma pneumoniae infection in children observed during a period of high incidence in henan, China. Heliyon. 2024;10(13):e33697. Published 2024 Jun 26.","journal-title":"Heliyon"},{"issue":"1","key":"11634_CR38","doi-asserted-by":"publisher","first-page":"e000262","DOI":"10.1136\/fmch-2019-000262","volume":"8","author":"MZI Chowdhury","year":"2020","unstructured":"Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam Med Community Health. 2020;8(1):e000262. Published 2020 Feb 16.","journal-title":"Fam Med Community Health"},{"issue":"1","key":"11634_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13052-025-01879-y","volume":"51","author":"PL Li","year":"2025","unstructured":"Li PL, Fu HM, Liu K, Li F, Yang JW. Effect of Bronchofiberscopic lavage with acetylcysteine instillation on refractory Mycoplasma pneumoniae pneumonia in children: a retrospective clinical observation. Ital J Pediatr. 2025;51(1):62. Published 2025 Feb 28.","journal-title":"Ital J Pediatr"},{"key":"11634_CR40","doi-asserted-by":"publisher","first-page":"1521954","DOI":"10.3389\/fped.2025.1521954","volume":"13","author":"R Ma","year":"2025","unstructured":"Ma R, Bai T, Yuan B, Zhang L, Li S, Ma L, et al. Risk factor analysis of plastic bronchitis among 126 children with macrolide-resistant Mycoplasma pneumoniae pneumonia with mutations at the A2063G site after bronchoscopy examination: a nomogram prediction model. Front Pediatr. 2025;13:1521954. Published 2025 Feb 27.","journal-title":"Front Pediatr"},{"issue":"1","key":"11634_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41390-021-01874-z","volume":"93","author":"L Wang","year":"2023","unstructured":"Wang L, Xie Q, Xu S, Li H, Zhang L, Ai J, et al. The role of flexible bronchoscopy in children with Mycoplasma pneumoniae pneumonia. Pediatr Res. 2023;93(1):198\u2013206.","journal-title":"Pediatr Res"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11634-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11634-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11634-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:10:08Z","timestamp":1759173008000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11634-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11634"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11634-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations expressed in the Declaration of Helsinki. This study was approved by the Ethics Committee of Zigong First People\u2019s Hospital to ensure adherence to ethical standards (Study Number: 2023-15). The Ethics Committee of Zigong First People\u2019s Hospital agreed to exempt patients from written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1198"}}